| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,173 | 21,468 | 19,455 | 18,573 | | Cost of Revenue | (10,312) | 15,972 | 14,876 | 19,310 | | | Gross Profit | 30,485 | 5,496 | 4,579 | (737) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 29,237 | 4,197 | 3,407 | (1,301) | | Non Recurring | 480 | 352 | 500 | 4,102 | | Others | 1,820 | 1,812 | 1,741 | 1,741 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,052) | (865) | (1,069) | (5,279) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 44 | 77 | 48 | (75) | | Earnings Before Interest And Taxes | (1,008) | (788) | (1,021) | (5,354) | | Interest Expense | 22 | 99 | 32 |
-
| | Income Before Tax | (1,030) | (887) | (1,053) | (5,354) | | Income Tax Expense | 5 | 30 | 30 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,035) | (917) | (1,083) | (5,354) | | | Non-recurring Events | | Discontinued Operations |
-
| 703 | (13) | (45) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,035) | (214) | (1,096) | (5,399) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,035) | ($214) | ($1,096) | ($5,399) |
|
0.59% Nasdaq 
Income Statement
